Dr Trish Holch
About Dr Trish Holch
Prior to joining Leeds Beckett in 2016, Trish worked as a Research Fellow in the Patient Reported Outcomes Group at the University of Leeds, and she continues as an Honorary Research Fellow there. Trish was awarded her PhD in Psychology from the University of Leeds in 2009, and a BSc (Hons) Psychology degree from the same institution in 2003.
Trish is the co-lead of the Centre for Psychological Research (PsyCen) Health & Clinical Psychology group at Leeds Beckett devoted to achieving the objectives and meeting the research needs specific to the REF2021
Trish is an executive committee member of the British Psychosocial Oncology Society (BPOS) and a member of the International Psycho-Oncology Society (IPOS), the ISOQOL (International Society for Quality of Life Research) and their Best Practices for PROs- Reporting Taskforce (Patient Reported Outcomes).
Trish regularly sits on the scientific committees of ISOQOL, BPOS and the National PROMs Research Conference and peer reviews manuscripts for Psycho-Oncology and the International Journal of Radiation Oncology Biology Physics.
In 2017 Trish co-edited a special section on digital technologies in the Journal of Cancer Survivorship Research and Practice and the accompanying editorial, ‘Introduction to special section on digital technology and cancer survivorship’
Trish is the leader for the BSc (Hons) Final Year Project module and the quantitative strand of the Advanced Research Methods and Applied Health Psychology in Medical Practice modules. She also lectures on the Health Psychology and Behavioural Neuroscience modules on the BSc (Hons) Psychology course.
Trish undertakes both qualitative and quantitative applied health research including validation of measures, cognitive interviewing and delphi consensus methodologies. Trish’s interests include understanding health behaviours, factors influencing self-management of symptoms, electronic symptom monitoring, PROMs and electronic health literacy.
Trish has presented her research at over 30 national and international conferences including the International Society for Quality of Life Research (Budapest), the International Psycho-Oncology Society Congress (Dublin), European Society for Radiotherapy and Oncology (ESTRO) (Barcelona, Vienna), National PROMs conference and the British Psychosocial Oncology Society. Trish has authored over 15 research papers in peer-reviewed journals including Annals of Oncology, International Journal of Radiation Oncology Biology Physics, British Medical Journal (Supportive and Palliative Care) and Acta Oncologica.
In 2017 Trish was invited to deliver a pre-meeting clinical course at the International ESTRO conference in Vienna alongside Professor Cai Grau from Aarhus University Hospital Denmark. The course was entitled ‘Current and potential future roles of Patient Reported Outcome Measures (PROMs) in radiotherapy’ and brought together a distinguished faculty of PROM researchers and clinicians from within and outside the radiotherapy community.
- A co-applicant on the Yorkshire Cancer Research Funded LiLAC (life after lung cancer project) which uses PROMs to enable comparison of two types of treatment for early stage lung cancer.
- A co-applicant on a Teenage Cancer Trust funded project developing a new model of emotional distress detection and management in teenagers and young adults (TYA) with cancer.
- University of Michigan, USA (orthopaedic department) to develop reporting guidelines for psychometric investigations of a Patient Reported Outcome Measure (PROM).
- University of Manchester and the Teenage Cancer trust to validate a Young Persons Cancer Awareness Measure (YPCAM).
- University of Leeds Patient Reported Outcomes Group on the National Institute of Health Research funded eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) Radiotherapy project.
- Radiotherapy department at St James’s Institute of Oncology (Leeds) to improve service delivery by developing innovative models of follow-up.
- Leeds Beckett University Diabetes Special Interest Research Group.